CBSET, a preclinical research company, announced that it has appointed Michael Naimark as director of business development.
Most recently, Mr. Naimark was employed by the Neural Stem Cell Institute (NSCI) as project manager overseeing the development of a cell-based therapy for macular degeneration under a 4-year award from the New York Stem Cell Foundation.

Previously, Mr. Naimark was co-owner of Care Research, a preclinical research organization where he provided operational, sales, and marketing oversight as Director of Surgical Models.

Prior to founding Care Research, Mr. Naimark helped launch Preclinical Research Services Inc., a preclinical research organization, and served as senior study director for several years. ■

• Haemonetics Corporation appoints Robert E. Abernathy to board
• Tetraphase Pharma appoints Kamalam Unninayar as CFO
• Boston Biomedical appoints Edgar Braendle as vice president
• Analogic Corporation appoints Joseph Whitters to board
• Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO

---

More inside POST